Efficient ligand discovery using sulfur(VI) fluoride reactive fragments

Aatkar, Arron and Vuorinen, Aini and Longfield, Oliver E. and Gilbert, Katharine and Peltier-Heap, Rachel and Wagner, Craig D. and Zappacosta, Francesca and Rittinger, Katrin and Chung, Chun-wa and House, David and Tomkinson, Nicholas C. O. and Bush, Jacob T. (2023) Efficient ligand discovery using sulfur(VI) fluoride reactive fragments. ACS Chemical Biology, 18 (9). pp. 1926-1937. ISSN 1554-8937 (https://doi.org/10.1021/acschembio.3c00034)

[thumbnail of Aatkar-etal-ACS-CB-2023-Efficient-ligand-discovery-using-sulfur-VI-fluoride]
Preview
 Text. Filename: Aatkar_etal_ACS_CB_2023_Efficient_ligand_discovery_using_sulfur_VI_fluoride.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (7MB)| Preview

Abstract

Sulfur(VI) fluorides (SFs) have emerged as valuable electrophiles for the design of "beyond-cysteine" covalent inhibitors and offer potential for expansion of the liganded proteome. Since SFs target a broad range of nucleophilic amino acids, they deliver an approach for the covalent modification of proteins without requirement for a proximal cysteine residue. Further to this, libraries of reactive fragments present an innovative approach for the discovery of ligands and tools for proteins of interest by leveraging a breadth of mass spectrometry analytical approaches. Herein, we report a screening approach that exploits the unique properties of SFs for this purpose. Libraries of SF-containing reactive fragments were synthesized, and a direct-to-biology workflow was taken to efficiently identify hit compounds for CAII and BCL6. The most promising hits were further characterized to establish the site(s) of covalent modification, modification kinetics, and target engagement in cells. Crystallography was used to gain a detailed molecular understanding of how these reactive fragments bind to their target. It is anticipated that this screening protocol can be used for the accelerated discovery of "beyond-cysteine" covalent inhibitors.

CORE (COnnecting REpositories)